A Study of Linvo-VR vs DVRd in Transplant-Eligible Adult Participants With Newly Diagnosed Multiple Myeloma (NDMM)
Clinical trial NCT07428369 · WITHDRAWN
Trial details
- NCT number
- NCT07428369
- Sponsor
- Regeneron Pharmaceuticals
- Status
- WITHDRAWN
- Phase
- Phase 2, Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2026-06-05
- Primary completion
- 2038-05-21
- Enrollment
- 0
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.